Modern Management of Heart Failure

This independent medical education programme is sponsored by Boehringer Ingelheim and Lilly Alliance (The Alliance). The Alliance had no influence over the agenda, programme development, content or selection of faculty. Editorial and content decisions were made solely by the Primary Care Cardiovascular Society and faculty chosen by Primary Care Cardiovascular Society.

The Primary Care Cardiovascular Society (PCCS) presents its second blended learning series of educational resources.

This series covers the recent data and guidance supporting the use of SGLT2is in the treatment of heart failure with reduced ejection fraction. The society has created guidance to its members around this topic and its place in the modern management of heart failure.

The series consists of five assets:

The blended learning series is accredited by the PCCS for CPD points.